Faculty of Veterinary Medicine, University of Glasgow, Glasgow, UK Murine MSCs are a readily available source of adult stem cells enabling extensive in vitro study of this cell population. MSCs have been described as multipotent, and have been proven capable of differentiation into several connective tissue types. Furthermore some studies have suggested an ability to differentiate into non-connective tissue cell types such as the cardiomyocyte. The aim of this study was to differentiate murine MSCs toward cardiac lineage with the commonly used method of culture with 5' Azacytidine. Critically, baseline analysis of gene expression of passage four MSCs demonstrated expression of key cardiac markers including cardiac troponin T and I, and the ryanodine receptor. Furthermore, expression analysis of these genes changed with time in culture and passage number. However, there was no significant alteration when cells were subjected to a differentiation protocol. This study therefore highlights the importance of analyzing baseline cells extensively, and indicates the limitations in extrapolating data for comparison between species. Furthermore this data brings into question the efficacy of cardiac differentiation using MSCs.
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Mesenchymal stem cells (MSCs) are defined using three key parameters; firstly adherence to tissue culture plastic, a simple and effective method of cell isolation; secondly conforming to specific surface antigen expression and finally, ability for multipotent differentiation in vitro (1) . In recent years, aided by ease of isolation and culture, this cell population has been extensively studied in relation to use of these adult stem cells as a therapeutic agent and source of cellular precursors for tissue regeneration.
Rodent modeling has created the foundation for research in this field, however characterization of MSCs is challenging given the wealth of markers available (2) . A number of studies across several species have shown that MSCs are capable of differentiating along three standard routes namely osteoblast, adipocyte, and chondrocyte cell types (2) (3) (4) (5) (6) (7) . Furthermore there is a suggestion that these mesodermal lineage cells have the ability to differentiate into non-connective tissue cell types such as neuronal, hepatocyte and cardiomyocyte (8) (9) (10) (11) (12) (13) .
In this study we obtained commercially available murine MSCs (Invitrogen) and characterized their marker expression following cardiac differentiation, and subsequently at different passage number. Murine MSCs were purchased from Invitrogen (Cat. No. 510502-01) and cultured in murine MSC media; DMEM low glucose containing Glutamax-I (Invitrogen), with 10% MSC qualified foetal bovine serum (FBS) (Invitrogen Cat. No. 12662-011) and 100 U/ml penicillin G and 100μg/ml streptomycin (both Invitrogen). Cells were plated at a cell density of 5,000 cells per cm 2 at 37 o C, 5% CO2 and exhibited a typical MSC morphology with flattened adherent cells with multi- ple jagged projections ( Fig. 1A, B ). Cells were passaged every 3∼4 days, and no evidence of senescence was observed until passage 18 when experiments were stopped; and no difference in cell morphology or passage behaviour was noted. Cells were characterized and found to be CD44 positive by both immunofluorescence (Fig. 1C , D) and RT-PCR ( Fig. 2) and CD45 negative by RT-PCR (data not shown). Total RNA was extracted from cell pellets using the RNeasy Ⓡ mini-kit (Qiagen), and 500 ng reverse transcribed using Omniscript Ⓡ RT (Qiagen). Primer pairs for murine markers were designed based on published sequences (NCBI) using Primer 3 software (http://primer3. sourceforge.net/) ( Table 1 ). Bands of corresponding size were sequenced and compared to the genome. Immunofluorescence was performed on early passage monolayer MSCs grown on 4-well chambered slides (Corning) using rabbit polyclonal to CD44 (Abcam, Ab65829) at 1：200, and secondary antibody Alexaflour 488 goat anti-rabbit IgG (H+L) (Invitrogen, A-11034) at 1：500. Murine MSCs were exposed to a cardiac differentiation protocol using the demethylating agent 5' Azacytidine (5' AZA). 5×10 4 cells in 0.5 ml media was added to each well of a 24-well plate with standard MSC media, and 3μM 5'AZA (Sigma) was added to the differentiated wells every 3 days for 3 weeks. Harvests of triplicate wells were taken at days 0, 7, 14 and 21 and RNA was subsequently extracted, and used for semi-quantitative RT-PCR using 100 ng RNA (Fig. 2 ). Vascular endothelial growth factor expression appeared to remain high and unchanged during the differentiation protocol in both test and control MSCs, compared to day 0. NKx2.5 remained at a similar expression level to day 0 across all the samples except for day 21 undifferentiated, where expression levels appeared lower. GATA 4 expression increased in differentiated samples over time. Flk-1 appeared to have higher expression levels in differentiated samples at all time points compared to day 0 and control cells. Smooth muscle actin (SMA) appeared to decrease in all samples when com- pared to day 0, with a more pronounced drop in expression seen in the undifferentiated samples at all time-points. Cardiac troponin I (CTI) appeared to increase in all samples when compared to day 0. The ryanodine receptor was expressed at very low levels in all samples. CD44 was expressed in all samples, with a slightly lower expression in undifferentiated samples compared to differentiated, and almost no expression seen in day 21 undifferentiated samples. Connexin 43 (CNX 43) expression appeared to be higher in all differentiated and control cells when compared to day 0. Murine MSCs did not express c-kit, a commonly used cardiac stem cell marker, or the β1-adrenergic receptor (Beta-1 Ad; data not shown).
Our results suggested that murine MSCs may be altering expression pattern over time, we therefore investigated the effects of passage number on the murine MSCs by comparing early (passage 4) and late passage (passage 18) cells. No alteration in morphology was seen over the time period and there was no suggestion of senescence, with cell numbers continuing to increase by a magnitude of 2∼ 3, even by the later passages. Using 500 ng total RNA and semi-quantitative RT-PCR it was seen that several markers demonstrated alterations in expression level (Fig. 3) .
Firstly it was noted that in this panel of markers we now saw both islet 1 and cardiac troponin T (CTT) expression, which had not been seen in the day 0 MSCs in the differentiation experiment. This may be explained by the five fold increase in total RNA used in the passage difference experiment, and therefore may indicate that RNA input is important when examining genes. Interestingly murine MSCs expressed CD34. It is generally accepted that MSCs should not express CD34 (1), however differences in CD34 expression has been observed in murine MSC populations, with interesting variation in the angiogenic potential be- tween positive and negative populations (14) . Furthermore we noted an increase in expression of islet 1, GATA 4, CTI, CTT, CD44 and CXN43, and a decrease in the expression of SMA from early to late passage respectively. These results taken in isolation could suggest movement toward a cardiac lineage expression profile simply as a function of culture duration. Key differences in MSC expression of cardiac lineage genes may be inadvertently used as proof of differentiation when we take into consideration that murine MSCs used in this study expressed genes deemed to be indicative of a cardiac phenotype at baseline and levels of expression altered by duration of culture alone. Alteration in gene expression by passage number has been reported previously in murine MSCs (15) and is therefore an important finding when analyzing results.
These results highlight the importance of interpretation of differentiation data, and in defining differentiation criteria prior to the experiment particularly in the context of species type and passage number and illustrate the importance of appropriate controls. Rodent MSCs have been described capable of cardiac differentiation using 5' AZA based upon cardiac marker expression (16) (17) (18) . This study aims to highlight the importance of fully analyzing baseline cells prior to experimentation and may warrant the need for global marker expression profiling studies. When making comparisons between MSC populations it is imperative to identify all confounding factors; species differences, site of MSC isolation, technique for isolation and passage number can all have an influence upon variation within MSC populations.
